BriaCell Therapeutics Corp.
BCTXW · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $26 | $26 | $27 | $0 |
| Gross Profit | -$26 | -$26 | -$27 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6,684 | $7,110 | $4,810 | $5,685 |
| G&A Expenses | $1,639 | $1,444 | $1,518 | $1,485 |
| SG&A Expenses | $1,639 | $1,444 | $1,518 | $1,485 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$1 |
| Operating Expenses | $8,323 | $8,555 | $6,328 | $7,169 |
| Operating Income | -$8,240 | -$8,484 | -$6,328 | -$7,169 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $44 | $387 | $103 | $832 |
| Pre-Tax Income | -$8,198 | -$8,097 | -$6,225 | -$6,338 |
| Tax Expense | $0 | $172 | $0 | $0 |
| Net Income | -$8,116 | -$8,025 | -$6,127 | -$6,291 |
| % Margin | – | – | – | – |
| EPS | -4.31 | -4.26 | -1,640.18 | -0.35 |
| % Growth | -1.2% | 99.7% | -468,522.9% | – |
| EPS Diluted | -4.31 | -4.26 | -1,640.18 | -0.35 |
| Weighted Avg Shares Out | 1,884 | 1,884 | 4 | 18,028 |
| Weighted Avg Shares Out Dil | 1,884 | 1,884 | 4 | 18,028 |
| Supplemental Information | – | – | – | – |
| Interest Income | $48 | -$87 | $27 | $47 |
| Interest Expense | $0 | -$37 | $37 | $0 |
| Depreciation & Amortization | $26 | $26 | $27 | $27 |
| EBITDA | -$8,169 | $18,536 | -$6,161 | -$7,143 |
| % Margin | – | – | – | – |